 |
 |
I know this subject has appeared in the past, but I was wondering if anyone could point me in the direction of the latest information on the use of Lucozade in OGTTs - different formulations and volumes etc that can be used. I have tried various other avenues and hit several brick walls so far! We are auditing how our GPs perform OGTTs, so I would also be interested to hear from anyone who has done anything similar, or whether labs produce guidance for their GPs and/or patients on the procedure. We were interested to note that the WHO criteria document (http://www.who.int/diabetes/currentpublications/en/) does not specifically state the levels of activity permissible during the test, or whether the patient can eat or drink during the 2 hours! Many thanks, Fiona Dr Fiona Riddoch Senior Clinical Biochemist Department of Clinical Biochemistry & Immunology Kingston Hospital x 3299 (direct dial 020 8934 3299) ACB South London Trainee Representative ------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/